Results 191 to 200 of about 84,160 (241)
Some of the next articles are maybe not open access.
Arylsulfonamide CB2 Receptor Agonists: SAR and Optimization of CB2 Selectivity
Bioorganic and Medicinal Chemistry Letters, 2008A high-throughput screening campaign resulted in the discovery of a highly potent dual cannabinoid receptor 1 (CB1) and 2 (CB2) agonist. Following a thorough SAR exploration, a series of selective CB2 full agonists were identified.
Brian W Dymock +2 more
exaly +3 more sources
Cannabinoid CB1 and CB2 Receptor Ligand Specificity and the Development of CB2-Selective Agonists
Current Medicinal Chemistry, 2008Cannabinoids in current use such as nabilone activate both CB1 and CB2 receptors. Selective CB2 activation may provide some of the therapeutic effects of cannabinoids, such as their immuno-modulatory properties, without the psychoactive effects of CB1 activation.
John C Ashton, Joel D. A. Tyndall
exaly +3 more sources
Targeting the Cannabinoid CB2 Receptor: Mutations, Modeling and Development of CB2 Selective Ligands
Current Medicinal Chemistry, 2005Since the discovery of the cannabinoid CB2 receptor in 1993, there has been a growing interest to clarify the importance of this G-protein coupled receptor (GPCR) for human physiology, and to investigate it as a possible target for current and future drug development.
K H, Raitio +4 more
openaire +2 more sources
NMR Characterization of Recombinant Transmembrane Protein CB2 Fragment CB2 180-233
Protein & Peptide Letters, 2006The expression of membrane proteins has been the bottleneck for their structural studies. Recently, we developed a method to obtain milligram quantities of isotope-labeled seven transmembrane G-protein coupled cannabinoid (CB) receptor fragment in E. coli.
J, Zhao, H, Zheng, X-Q, Xie
openaire +2 more sources
Mini-Reviews in Medicinal Chemistry, 2005
The CB(1) receptor is found principally in the central nervous system and is responsible for the overt physiological effects of cannabinoids. In contrast, the CB(2) receptor is expressed primarily in the immune system and is responsible for few, if any, obvious behavioral effects.
openaire +2 more sources
The CB(1) receptor is found principally in the central nervous system and is responsible for the overt physiological effects of cannabinoids. In contrast, the CB(2) receptor is expressed primarily in the immune system and is responsible for few, if any, obvious behavioral effects.
openaire +2 more sources
Bioorganic & Medicinal Chemistry Letters, 2011
A new series of imidazopyridine CB2 agonists is described. Structural optimization improved CB2/CB1 selectivity in this series and conferred physical properties that facilitated high in vivo exposure, both centrally and peripherally. Administration of a highly selective CB2 agonist in a rat model of analgesia was ineffective despite substantial CNS ...
B Wesley, Trotter +19 more
openaire +2 more sources
A new series of imidazopyridine CB2 agonists is described. Structural optimization improved CB2/CB1 selectivity in this series and conferred physical properties that facilitated high in vivo exposure, both centrally and peripherally. Administration of a highly selective CB2 agonist in a rat model of analgesia was ineffective despite substantial CNS ...
B Wesley, Trotter +19 more
openaire +2 more sources
Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Current Medicinal Chemistry, 2013Cannabinoids have potential therapeutic value e.g. in pain relief, cancer therapy, control of nausea and vomiting, and appetite stimulation, but their therapeutic benefits are limited by unwanted central nervous system (CNS) side-effects. Separating the therapeutic effects of cannabinoid agonists from their undesired CNS effects can be achieved by ...
openaire +3 more sources
To CB2 or not CB2: Revisiting renoprotection in acute and chronic kidney injury
British Journal of PharmacologyAbstract The cannabinoid receptor 2 (CB2), which is encoded by the Cnr2 gene, is a G‐protein‐coupled receptor that controls immune responses and has recently emerged as a regulator of renal injury and repair.
Jonathan M. de Jesus +2 more
openaire +2 more sources
To CB2 or Not CB2: Revisiting Renoprotection in AKI and CKD
Cannabinoid receptor 2 (CBS) is a G-protein coupled receptor that controls immune responses and has recently emerged as a regulators of renal injury and repair. Over the past 15 years, numerous pharmacological and genetics studies have explored the role of CB2 in acute kidney injury (AKI) and chronic kidney disease (CKD). Using a wide array of chemical,Jonathan de Jesus, Bob Moore, Frank Park
openaire +1 more source

